These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23268365)
1. A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon. Hummers LK; Dugowson CE; Dechow FJ; Wise RA; Gregory J; Michalek J; Yenokyan G; McGready J; Wigley FM Ann Rheum Dis; 2013 Dec; 72(12):1962-7. PubMed ID: 23268365 [TBL] [Abstract][Full Text] [Related]
2. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Chung L; Shapiro L; Fiorentino D; Baron M; Shanahan J; Sule S; Hsu V; Rothfield N; Steen V; Martin RW; Smith E; Mayes M; Simms R; Pope J; Kahaleh B; Csuka ME; Gruber B; Collier D; Sweiss N; Gilbert A; Dechow FJ; Gregory J; Wigley FM Arthritis Rheum; 2009 Mar; 60(3):870-7. PubMed ID: 19248104 [TBL] [Abstract][Full Text] [Related]
3. The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon. Friedman EA; Harris PA; Wood AJ; Stein CM; Kurnik D Clin Pharmacol Ther; 2007 Apr; 81(4):503-9. PubMed ID: 17301734 [TBL] [Abstract][Full Text] [Related]
4. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476 [TBL] [Abstract][Full Text] [Related]
5. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon. Whitmore SE; Wigley FM; Wise RA J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study. Wise RA; Wigley FM; White B; Leatherman G; Zhong J; Krasa H; Kambayashi J; Orlandi C; Czerwiec FS Arthritis Rheum; 2004 Dec; 50(12):3994-4001. PubMed ID: 15593189 [TBL] [Abstract][Full Text] [Related]
7. Reduced perfusion in systemic sclerosis digital ulcers (both fingertip and extensor) can be increased by topical application of glyceryl trinitrate. Hughes M; Moore T; Manning J; Wilkinson J; Dinsdale G; Roberts C; Murray A; Herrick AL Microvasc Res; 2017 May; 111():32-36. PubMed ID: 28027937 [TBL] [Abstract][Full Text] [Related]
8. Therapy: A local approach to Raynaud phenomenon. Herrick AL Nat Rev Rheumatol; 2009 May; 5(5):246-7. PubMed ID: 19412190 [TBL] [Abstract][Full Text] [Related]
9. Topical nitroglycerin and lidocaine locally vasodilate the radial artery without affecting systemic blood pressure: a dose-finding phase I study. Majure DT; Hallaux M; Yeghiazarians Y; Boyle AJ J Crit Care; 2012 Oct; 27(5):532.e9-13. PubMed ID: 22699036 [TBL] [Abstract][Full Text] [Related]
10. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170 [TBL] [Abstract][Full Text] [Related]
11. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days. Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878 [TBL] [Abstract][Full Text] [Related]
12. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Fries R; Shariat K; von Wilmowsky H; Böhm M Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885 [TBL] [Abstract][Full Text] [Related]
13. An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects. Kernohan AF; McIntyre M; Hughes DM; Tam SW; Worcel M; Reid JL Br J Clin Pharmacol; 2005 Jan; 59(1):85-93. PubMed ID: 15606445 [TBL] [Abstract][Full Text] [Related]
15. Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis. Anderson ME; Moore TL; Hollis S; Jayson MI; King TA; Herrick AL Rheumatology (Oxford); 2002 Mar; 41(3):324-8. PubMed ID: 11934971 [TBL] [Abstract][Full Text] [Related]
16. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group. Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148 [TBL] [Abstract][Full Text] [Related]
17. Acute effects of misoprostol on digital circulation in patients with Raynaud's phenomenon. Wise RA; Wigley F J Rheumatol; 1994 Jan; 21(1):80-3. PubMed ID: 8151594 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
19. Transcutaneous nitroglycerine in the treatment of erectile dysfunction: a placebo controlled clinical trial. Gramkow J; Lendorf A; Zhu J; Meyhoff HH Int J Impot Res; 1999 Feb; 11(1):35-9. PubMed ID: 10098952 [TBL] [Abstract][Full Text] [Related]